Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men

AIDS

Volumn 18, Issue 5, 2004, Pages 793-798

  Morris, Alison ^a,b,e   Kingsley, Lawrence A ^c   Groner, Gena ^d   Lebedeva, Irina P ^a   Beard, Charles B ^d   Norris, Karen A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e School of Medicine ^*  (United States)

Author keywords

Colonization; HIV infection; Multicenter AIDS Cohort; PCP; Pneumocystis jiroveci

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; PROTOZOAL DNA; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANAMNESIS; ARTICLE; AUTOPSY; CAUSE OF DEATH; CIGARETTE SMOKING; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA ANALYSIS; DNA EXTRACTION; GEOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INCIDENCE; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA; PNEUMOCYSTOSIS; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUTOPSY; CITIES; DIHYDROPTEROATE SYNTHASE; DNA, FUNGAL; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; MUTATION; PNEUMOCYSTIS CARINII; PNEUMONIA, PNEUMOCYSTIS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; UNITED STATES;

EID: 2042503030     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200403260-00011     Document Type: Article

References (29)

1. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretorival therapy. Clin Infect Dis 2000, 30 (Suppl 1):S5-S14.
2. Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002, 8:891-896.
3. Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, Hopkin JM. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol 1990, 43:69-76.
4. Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, Hopkin JM. Detection of Pneumocystis carinii with DNA amplification. Lancet 1990, 336:451-453.
5. Leigh TR, Kangro HO, Gazzard BG, Jeffries DJ, Collins JV. DNA amplification by the polymerase chain reaction to detect subclinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms. Respir Med 1993, 87:525-529.
6. Olsson M, Elvin K, Lofdahl S, Linder E. Detection of Pneumocystis carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction. J Clin Microbiol 1993, 31: 221-226.
7. Leibovitz E, Pollack H, Moore T, Papellas J, Gallo L, Krasinski K, et al. Comparison of PCR and standard cytological staining for detection of Pneumocystis carinii from respiratory specimens from patients with or at high risk for infection by human immunodeficiency virus. J Clin Microbiol 1995, 33:3004-3007.
8. Rabodonirina M, Raffenot D, Cotte L, Boibieux A, Mayencon M, Bayle G, et al. Rapid detection of Pneumocystis carinii in bronchoalveolar lavage specimens from human immunodeficiency virus-infected patients: use of a simple DNA extraction procedure and nested PCR. J Clin Microbiol 1997, 35:2748-2751.
9. Matos O, Costa MC, Lundgren B, Caldeira L, Aguiar P, Antunes F. Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections. Eur J Clin Microbiol Infect Dis 2001, 20:573-575.
10. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR, Jr. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987, 126:310-318.
11. Wakefield AE. DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora. J Clin Microbiol 1996, 34:1754-1759.
12. Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura IN, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000, 6:265-272.
13. Lane BR, Ast JC, Hossler PA, Mindell DP, Bartlett MS, Smith JW, et al. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis 1997, 175:482-485.
14. Kazanjian P, Locke AB, Hossler PA, Lane BR, Bartlett MS, Smith JW, et al. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 1998, 12:873-878.
15. Mei Q, Gurunathan S, Masur H, Kovacs JA. Failure of cotrimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene. Lancet 1998, 351:1631-1632.
16. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999, 354:1347-1351.
17. Wakefield AE, Lindley AR, Ambrose HE, Denis CM, Miller RF. Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients. J Infect Dis 2003, 187:901-908.
18. Dohn MN, White ML, Vigdorth EM, Buncher CR, Hertzberg VS, Baughman RP, et al. Geographic clustering of Pneumocystis carinii pneumonia in patients with HIV infection. Am J Respir Crit Care Med 2000, 162:1617-1621.
19. Morris AM, Swanson M, Ha H, Huang L. Geographic distribution of human immunodeficiency virus-associated Pneumocystis carinii pneumonia in San Francisco. Am J Respir Crit Care Med 2000, 162:1622-1626.
20. Hoover DR, Graham NM, Bacellar H, Schrager LK, Kaslow R, Visscher B, et al. Epidemiologic patterns of upper respiratory illness and Pneumocystis carinii pneumonia in homosexual men. Am Rev Respir Dis 1991, 144:756-759.
21. Miller RF, Grant AD, Foley NM. Seasonal variation in presentation of Pneumocystis carinii pneumonia. Lancet 1992, 339: 747-748.
22. Navin TR, Rimland D, Lennox JL, Jernigan J, Cetron M, High-tower A, et al. Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus. J Infect Dis 2000, 181:158-164.
23. Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. AIDS 1996, 10: 1121-1126.
24. Galai N, Park LP, Wesch J, Visscher B, Riddler S, Margolick JB. Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14: 451-458.
25. Stansell JD, Osmond DH, Charlebois E, LaVange L, Wallace JM, Alexander BV, et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1997, 155:60-66.
26. Nieman RB, Fleming J, Coker RJ, Harris JR, Mitchell DM. The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS 1993, 7:705-710.
27. Ma L, Borio L, Masur H, Kovacs JA. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J Infect Dis 1999, 180:1969-1978.
28. Huang L, Beard CB, Creasman J, Levy D, Duchin JS, Lee S, et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis 2000, 182:1192-1198.
29. Navin TR, Beard CB, Huang L, del Rio C, Lee S, Pieniazek NJ, et al. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. Lancet 2001, 358:545-549.